X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4280) 4280
Publication (468) 468
Book Review (17) 17
Book Chapter (14) 14
Newsletter (11) 11
Dissertation (5) 5
Conference Proceeding (4) 4
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3713) 3713
male (2980) 2980
injections, intraventricular (2930) 2930
rats (2582) 2582
neurosciences (1332) 1332
index medicus (1330) 1330
female (1028) 1028
rats, sprague-dawley (946) 946
humans (738) 738
brain (734) 734
infusions, intraventricular (719) 719
mice (630) 630
rats, wistar (622) 622
dose-response relationship, drug (584) 584
pharmacology & pharmacy (529) 529
endocrinology & metabolism (525) 525
physiology (426) 426
brain - drug effects (425) 425
blood pressure - drug effects (424) 424
time factors (416) 416
rats, inbred strains (413) 413
disease models, animal (359) 359
neurons (355) 355
brain - metabolism (353) 353
rat (340) 340
clinical neurology (316) 316
eating - drug effects (305) 305
physiological aspects (295) 295
research (291) 291
behavior, animal - drug effects (264) 264
neurons - drug effects (257) 257
motor activity - drug effects (248) 248
food-intake (245) 245
heart rate - drug effects (245) 245
central-nervous-system (244) 244
intraventricular hemorrhage (238) 238
article (232) 232
hypothalamus (228) 228
expression (225) 225
angiotensin ii - pharmacology (212) 212
mice, inbred c57bl (210) 210
neurology (210) 210
immunohistochemistry (206) 206
neurons - metabolism (205) 205
rat-brain (204) 204
body weight - drug effects (202) 202
blood pressure (190) 190
rodents (190) 190
hippocampus - drug effects (189) 189
injections, intravenous (189) 189
cerebral ventricles - drug effects (183) 183
hippocampus (182) 182
psychiatry (182) 182
analysis (180) 180
behavioral sciences (179) 179
infusions, intravenous (177) 177
infusion (174) 174
biochemistry & molecular biology (173) 173
hypothalamus - metabolism (171) 171
adult (170) 170
sheep (169) 169
brain - physiology (166) 166
paraventricular nucleus (165) 165
cerebral ventricles - physiology (164) 164
hypothalamus - drug effects (162) 162
middle aged (161) 161
receptors (161) 161
leptin (160) 160
messenger-rna (159) 159
receptor (158) 158
pediatrics (156) 156
dopamine (155) 155
food intake (155) 155
surgery (154) 154
gene-expression (151) 151
peripheral vascular disease (147) 147
treatment outcome (147) 147
analysis of variance (144) 144
health aspects (143) 143
stress (143) 143
vasopressin (143) 143
body-weight (142) 142
obesity (140) 140
alzheimers-disease (138) 138
in-vivo (135) 135
insulin (134) 134
maze learning - drug effects (133) 133
feeding behavior - drug effects (132) 132
hormones, hormone substitutes, and hormone antagonists (132) 132
nervous system (131) 131
peptide fragments - pharmacology (130) 130
hippocampus - metabolism (129) 129
aged (125) 125
drinking - drug effects (125) 125
central nervous system (123) 123
angiotensin ii - administration & dosage (121) 121
infant, newborn (121) 121
injections, intraperitoneal (121) 121
research article (120) 120
blood-pressure (119) 119
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4248) 4248
Japanese (14) 14
Russian (7) 7
French (6) 6
German (6) 6
Spanish (6) 6
Chinese (5) 5
Ukrainian (3) 3
Korean (2) 2
Polish (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurotoxicology, ISSN 0161-813X, 12/2011, Volume 32, Issue 6, pp. 836 - 844
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 11/2017, Volume 174, Issue 22, pp. 4173 - 4185
Journal Article
Diabetologia, ISSN 0012-186X, 11/1997, Volume 40, Issue 11, pp. 1269 - 1277
Neuropeptide Y in the hypothalamus is a potent physiological stimulator of feeding, and may contribute to the characteristic metabolic defects of obesity when... 
hypothalamo-pituitary adrenal axis | proinsulin | vagus nerve | glucose utilisation | Medicine & Public Health | Human Physiology | Intracerebroventricular | insulin | Metabolic Diseases | neuropeptide Y | Internal Medicine | NERVOUS-SYSTEM | ACID | INVOLVEMENT | ENERGY-BALANCE | CUSHINGS-SYNDROME | OBESITY | CORTICOTROPIN-RELEASING FACTOR | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | intracerebroventricular | BETA-CELL | ADIPOSE-TISSUE | Injections, Intraventricular | Body Weight - drug effects | Neuropeptide Y - administration & dosage | Muscle, Skeletal - metabolism | Chromatography, High Pressure Liquid | Insulin - blood | Corticotropin-Releasing Hormone - analysis | Adipose Tissue - metabolism | Time Factors | Radioimmunoassay | Female | Corticosterone - blood | Hypothalamus - drug effects | Adrenocorticotropic Hormone - blood | Pituitary-Adrenal System - physiology | Pituitary-Adrenal System - drug effects | Hypothalamus - physiology | Rats | Glucose - pharmacology | Rats, Sprague-Dawley | Vagotomy | Eating - drug effects | Vagus Nerve - physiology | Organ Size - drug effects | Animals | Pancreas - anatomy & histology | Glucose - metabolism | Neuropeptide Y | Corticotropin releasing hormone | Glucose metabolism | Corticosterone | Physiological aspects | ACTH | Insulin resistance | Universities and colleges | Glucose | Dextrose
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e64452
This study presents a computational tool for auto-segmenting the distribution of brain infusions observed by magnetic resonance imaging. Clinical usage of... 
IMAGE SEGMENTATION | TRIAL | RECURRENT MALIGNANT GLIOMA | NEUROTROPHIC FACTOR | MULTIDISCIPLINARY SCIENCES | PRIMATE BRAIN | GENE-THERAPY | PARKINSON-DISEASE | MR-IMAGES | PHASE-I | CONVECTION-ENHANCED DELIVERY | Gadolinium - administration & dosage | Neuroimaging | Dependovirus - genetics | Genetic Therapy | Thalamus - metabolism | Genetic Vectors - administration & dosage | Heterocyclic Compounds - administration & dosage | Gadolinium - pharmacokinetics | Contrast Media - pharmacokinetics | Image Interpretation, Computer-Assisted | Organometallic Compounds - pharmacokinetics | Magnetic Resonance Imaging | Algorithms | Animals | Contrast Media - administration & dosage | Primates | Heterocyclic Compounds - pharmacokinetics | Software | Genetic Vectors - pharmacokinetics | Infusions, Intraventricular | Observer Variation | Organometallic Compounds - administration & dosage | Putamen - metabolism | Gene therapy | Contrast media | Brain | Nuclear magnetic resonance--NMR | Segmentation | Image processing | Computational neuroscience | Noise | Physicians | Brain cancer | Variability | Clinical trials | Gadolinium | Oncology | Neurosurgery | Infusion | Thalamus | Standard deviation | Medical personnel | Medical research | Automation | Medical imaging | Monkeys & apes | Putamen | Image segmentation | Hand tools | Magnetic resonance imaging | Data sets | Computer applications | Resonance | Tumors | Nuclear magnetic resonance | NMR
Journal Article
Hypertension, ISSN 0194-911X, 02/2015, Volume 65, Issue 2, pp. 352 - 361
We previously reported that binding of prorenin to the (pro)renin receptor (PRR) plays a major role in brain angiotensin II formation and the development of... 
(pro)renin receptor | hypertension | central nervous system | BRAIN ANGIOTENSIN | CONVERTING ENZYME | CELLS | NONPROTEOLYTIC ACTIVATION | HUMAN PRORENIN | RENIN-ANGIOTENSIN SYSTEM | NEURONS | PERIPHERAL VASCULAR DISEASE | RAT-BRAIN | HANDLE-REGION PEPTIDE | EXPRESSION | Captopril - pharmacology | Calcium - metabolism | Humans | Receptors, Cell Surface - analysis | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Extracellular Signal-Regulated MAP Kinases - metabolism | Neuroblastoma | Receptors, Cell Surface - antagonists & inhibitors | Renin - therapeutic use | Protein Processing, Post-Translational - drug effects | Hypertension - chemically induced | Renin - administration & dosage | Hypertension - prevention & control | Ion Transport - drug effects | Blood Pressure - drug effects | Hypertension - genetics | Hypothalamus - drug effects | Phosphorylation - drug effects | Hypothalamus - chemistry | Binding, Competitive | Mice, Inbred C57BL | Peptide Fragments - administration & dosage | Losartan - pharmacology | Antihypertensive Agents - therapeutic use | Sodium Chloride - toxicity | Baroreflex - drug effects | Vacuolar Proton-Translocating ATPases - antagonists & inhibitors | Animals | Desoxycorticosterone Acetate - toxicity | Angiotensin II - analysis | Cell Line, Tumor | Mice | Peptide Fragments - therapeutic use | Infusions, Intraventricular | Vacuolar Proton-Translocating ATPases - analysis | Angiotensin II - physiology
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, ISSN 0363-6135, 08/2012, Volume 303, Issue 3, pp. H393 - H400
Guimaraes PS, Santiago NM, Xavier CH, Velloso EP, Fontes MA, Santos RA, Campagnole-Santos MJ. Chronic infusion of angiotensin(1-7) into the lateral ventricle... 
SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | baroreflex | HEART-FAILURE | collagen | deoxycorticosterone acetate-salt | NOREPINEPHRINE RELEASE | NUCLEUS-TRACTUS-SOLITARII | BLOOD-PRESSURE | CARDIAC-HYPERTROPHY | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | RECEPTOR MAS | BARORECEPTOR REFLEX MODULATION | renin-angiotensin system | BAROREFLEX CONTROL | Sympathetic Nervous System - drug effects | Angiotensin II - blood | Antihypertensive Agents - administration & dosage | Lateral Ventricles | Male | Sympathetic Nervous System - physiopathology | RNA, Messenger - metabolism | Brain - metabolism | Heart Rate - drug effects | Collagen Type I - genetics | Time Factors | Hypertension - chemically induced | Peptide Fragments - blood | Hypertension - prevention & control | Blood Pressure - drug effects | Disease Models, Animal | Brain - physiopathology | Peptide Fragments - administration & dosage | Angiotensin I - administration & dosage | Desoxycorticosterone | Rats | Angiotensin I - blood | Collagen Type III - genetics | Rats, Sprague-Dawley | Hypertension - physiopathology | Antihypertensive Agents - blood | Hypertension - metabolism | Baroreflex - drug effects | Brain - drug effects | Animals | Heart Ventricles - physiopathology | Kidney - innervation | Heart Ventricles - metabolism | Infusions, Intraventricular | Heart Ventricles - drug effects | Hypertension | Physiological aspects | Control | Angiotensin
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 2016, Volume 311, Issue 6, pp. E939 - E948
Previous studies have shown that very lowdose infusions of leptin into the third or the fourth ventricle alone have little effect on energy balance, but... 
Energy expenditure | Rats | Food intake | Body composition | CHOLECYSTOKININ | PHYSIOLOGY | PHOSPHORYLATION | FOOD-INTAKE | energy expenditure | BODY-WEIGHT | body composition | HINDBRAIN | NUCLEUS | IN-VIVO | ENDOCRINOLOGY & METABOLISM | NEURONS | rats | FAT DEPOTS | food intake | Phosphoproteins - drug effects | Phosphatidylinositol 3-Kinase - drug effects | Male | Mitogen-Activated Protein Kinase 1 - drug effects | Phosphoproteins - metabolism | Rhombencephalon - drug effects | Phosphatidylinositol 3-Kinases | Dose-Response Relationship, Drug | Mitogen-Activated Protein Kinase 3 - drug effects | Liver - drug effects | Fourth Ventricle | Leptin - pharmacology | Hypothalamus - drug effects | Phosphatidylinositol 3-Kinase - metabolism | STAT3 Transcription Factor - metabolism | Uncoupling Protein 1 - drug effects | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - drug effects | Uncoupling Protein 1 - metabolism | Liver - metabolism | Rats, Sprague-Dawley | Blotting, Western | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism | Animals | Hypothalamus - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | STAT3 Transcription Factor - drug effects | Suppressor of Cytokine Signaling 3 Protein - drug effects | Rhombencephalon - metabolism | Adipose Tissue, Brown - drug effects | Adipose Tissue, Brown - metabolism | Infusions, Intraventricular | Suppressor of Cytokine Signaling 3 Protein - metabolism | Energy Metabolism - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Cellular signal transduction | Genetic aspects | Genetic transcription | Health aspects | Leptin
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 4/2015, Volume 232, Issue 8, pp. 1415 - 1426
Journal Article